Skip to main content
Normal View

COMMITTEE OF PUBLIC ACCOUNTS debate -
Thursday, 15 Jan 2004

Department of Health and Children — Value for Money Report on The Waiting List Initiative.

Mr. Michael Kelly, (Secretary General, Department of Health and Children), called and examined.

I welcome everybody to the committee. Witnesses should be aware that they do not enjoy absolute privilege. As and from 2 August 1998, section 10 of the Committees of the Houses of the Oireachtas (Compellability, Privileges and Immunities of Witnesses) Act 1997 granted certain rights to persons who are identified in the course of the committee's proceedings. These rights include the right to give evidence, produce or send documents to the committee, appear before the committee either in person or through a representative, make a written and oral submission, request the committee to direct the attendance of witnesses and the production of documents and the right to cross-examine witnesses. For the most part, these rights can be exercised only with the consent of the committee. Persons invited before the committee are made aware of these rights and any person identified in the course of proceedings who is not present may have to be made aware of them and provided with the transcript of the relevant part of the committee's proceedings if the committee considers it appropriate in the interests of justice.

Notwithstanding this provision in legislation I should remind members of the long-standing parliamentary practice to the effect that Members should not comment on, criticise or make charges against a person outside the House or an official, either by name or in such a way as to make him or her identifiable. Members are also reminded of the provisions that within Standing Order 156, the committee should also refrain from inquiring into the merits of a policy or policies of the Government or a Minister of the Government or the merits of the objectives of such policies. I invite Mr. Kelly, Secretary General of the Department of Health and Children, to introduce his officials.

Mr. Michael Kelly

The officials with me are Pat O'Byrne, who manages the national treatment purchase fund; Mr. Robbie Breen, assistant principal in the hospitals division in the Department and Dr. Tony O'Holohan, deputy chief medical officer.

Mr. Michael Lyons

I am the chief executive of the Eastern Regional Health Authority. May I introduce my colleagues, Mr. Jim Breslin director of planning commissioning and change at the authority, who is responsible for the contracting and commissioning of waiting list initiative work; Mr. Liam Woods, director of finance in the authority and Ms Angela Fitzgerald, director of monitoring and evaluation who is involved in the monitoring and reporting on waiting list initiative work.

Mr. Joe Mooney

I am in the public expenditure division of the Department of Finance, and my colleague, Mr. Larry Dunne, is an assistant principal in the same division.

The Comptroller and Auditor General, Mr. Purcell, will introduce the value for money report.

Mr. John Purcell

The waiting list initiative was introduced in 1993 to deal with the persistent problem of significant numbers of patients waiting long periods of time for elective, that is non-emergency treatment in acute hospitals. In launching the initiative the Department for the first time set targets for the maximum length of time patients had to wait for treatment in nine specialties. These are set out in figure 1.1 of the report and represented surgical procedures which had the longest waiting lists at the time. The maximum waiting time set for the initiative was 12 months for adults and six months for children. Between its introduction in 1993 and the end of 2003, a total of €290 million was provided under the initiative. These funds were intended to be kept separate from the normal core funding of the acute hospitals and to be used to increase the number of elective surgical procedures being undertaken, thereby reducing the number of patients waiting longer the target maximum times.

The money provided under the initiative took a long time to make a significant impact on the number of long waiters and it was not until 2000 that meaningful reductions began to be seen. Since then the numbers of long waiters in the selected categories have generally been falling and the latest figures for September 2003 show that 6,530 patients were waiting for treatment in those categories for longer than the target maximum times. This represents a big improvement over previous years and is attributable not only to the effect of the initiative but also to the impact of increased funding generally for acute hospitals and, latterly, to the operation of the national treatment purchase fund. The residual problem is mainly in the eastern region with four Dublin hospitals accounting for over half the reported long-waiting patients at the end of 2002 but even there the situation is improving. Based on the latest figures at the end of September 2003, estimates of average waiting time show meaningful reductions over 2002 figures.

Our examination concentrated on the period 1998-2002 when most of the money, that is €172 million, was spent. From our examination we found that there was a lack of clarity about what the waiting list initiative money was intended to cover. For example, for a long time, there was confusion at hospital level as to whether day cases were to be included. While the targeted money appeared to have been applied to activities designed to achieve the general aims of the initiative, there was a lack of traceability in the hospitals we visited as to how the funds were used. By 2002, almost half the funds were being used to pay for staff posts that had been made or were about to be made permanent. While this was a legitimate way of using the funds and as human resources were required to improve the listing, it had the effect of restricting the flexibility to channel funds to the most problematic areas. We also found that systems needed to be developed to gather and analyse information which will help to assess the effectiveness of the money spent in this area. For example, information on comparative waiting times for public and private patients would be useful as would information on the time spent by individuals awaiting a hospital out-patient appointment with a consultant, which historically has not been taken into account in calculating the overall waiting times for patients waiting for elective treatment.

The advent of the national treatment purchase fund in 2002 gave a much needed boost to activity geared to shortening the waiting lists. The way in which it operates provides a clear link between the money granted and the effect of the money being applied. I am glad to note that the Minister in his response to my report has stated that waiting list funding will in future be channelled through the national treatment purchase fund, that is money that is not already committed to permanent resources which will become part of the core funding of acute hospitals in the future. At a minimum, this should help to refocus the initiative to the attainment of its primary objective of ensuring that no one should have to endure an excessive wait for an elective procedure.

Mr. Kelly

The Department of Health and Children welcomes the publication of the Comptroller and Auditor General's report on the waiting list initiative. Since the waiting list initiative was introduced in 1993 many thousands of patients had elective treatments more quickly than would otherwise have been the case. As the report has acknowledged and documented, the initiative has resulted in a significant number of important achievements. There has been a reduction of 54% in the number of patients waiting longer than the target times between 1998 and 2003 from 14,100 to 6,530. There has been a decrease in waiting lists for many specialities, particularly cardiac surgery which decreased from around 1,000 at the start of 1998 to 55 by the end of 2002. The number waiting for vascular surgery has been reduced by 60% and in the speciality of gynaecology the numbers were cut by half.

I am conscious, however, that while we tend to discuss this topic in terms of statistics, each case represents a person who has been judged by his or her consultant as needing a specified medical procedure. In an ideal world, one would not wish to see significant waiting time for any health service that was needed but, as pointed out in the report, this would require maintaining a level of spare capacity which could be expensive and wasteful.

Over the last two or three decades there have been numerous important advances in hospital services, particularly surgical technology, and in anaesthesia. These advances have improved greatly the range, safety and effectiveness of the surgical procedures that can be offered by modern health systems. However, as a consequence, there have been dramatic increases in the demand for surgical procedures, especially elective procedures. This is a dynamic situation which changes each year.

The nature of our health care system is such that not all treatments can be made available to patients immediately. The committee will be aware that there are two streams to hospital activity, emergency and elective. Pressures on the hospital system due to identified capacity constraints hinder its ability to provide elective activity in a planned way because of the urgent and unpredictable needs of emergency patients. This is a complex area and compounded by difficulties relating to the less than adequate availability of long-stay beds and other supports in the community. Patients who require elective treatment may have to wait because beds, staff and operating theatres are being used to treat emergency cases. Eliminating waiting lists entirely would mean having spare capacity in the system to deal with peaks in demand. The balance to be achieved is to ensure that the available resources are used efficiently and that treatment can be delivered to patients in a reasonable time.

The waiting list initiative contributed to a 25% increase in acute hospital activity in the period 1997 to 2002, while day case work increased by 60% in the same period. There has been a rapid movement in the last few years towards day case work. As a result, a variety of routine and complex treatments, surgery and diagnostic tests can now be performed with the patient being admitted and discharged from hospital on the same day. More than 50% of all elective surgery is now performed on a day case basis. This was one of the targets set out in the health strategy and it is a deliberate objective of policy to move in that direction.

In the statistics on acute hospital discharges, it is notable that of 957,997 discharges in 2002, over 400,000 were day cases. It is also notable that total activity in the acute hospitals between 1993 and 2002 increased by 35%. The Comptroller and Auditor General's report noted that between 1998 and the end of 2002, and particularly from 2000, the reported number of patients waiting longer than the target maximum waiting times for elective treatment decreased by 39% from 14,100 to 8,700. The latest waiting list figures for the quarter ended 30 September 2003 show that the reported number of those waiting a long time has decreased to 6,530, representing a 54% reduction since 1998. The health strategy contains a commitment to reform the organisation and management of waiting lists. While the waiting list policy has been the subject of regular review, the analysis carried out during the preparation of the strategy indicated the need to take further measures to reduce waiting times for patients. This led to the establishment of the national treatment purchase fund, NTPF, which has proved to be successful with over 9,700 patients treated up to the end of 2003.

The introduction of the fund has had other beneficial effects. In particular, the NTPF estimates that a significant percentage of patients could be removed from the waiting lists because they no longer required or wished to have treatment. Similarly, the NTPF has shown the benefit of using private sector input where appropriate. It has been suggested that the Department was reluctant to indicate that long waiting patients be targeted by the waiting list initiative. The Department acknowledges that a particular focus of the initiative was to deal with those waiting longest in the nine target surgical specialities. However, there was more than one objective to be addressed under the initiative, which is acknowledged in the report. It had four distinct objectives. It aimed to achieve a significant reduction in the number of public patients awaiting elective procedures; increase the number of persons receiving elective procedures; reduce the times persons are waiting for elective procedures in the target specialities to a maximum of 12 months for adults and six months for children; and improve the management of elective procedures, waiting lists and waiting times. To focus on one of these at the exclusion of the others would be a mistake in an analysis of the initiative's overall impact.

Attention has been drawn to the fact that substantial amounts of waiting list initiative funding were spent on staffing costs. It is inevitable that a significant proportion of spending under the waiting list initiative would relate to staff costs. There is no other way of delivering activity. Many hospitals use waiting list funding to employ extra waiting list staff and bed management staff. In this context the report notes that the hospitals visited during the course of the review have a more active management of waiting lists and waiting times and better hospital bed utilisation. This suggests a gain in efficiency in the overall management of patient throughput, apart from the direct improvement of waiting list management.

With regard to permanent consultant posts, once services were put in place and were successful in dealing with local need, there was a compelling case to transform the short-term and temporary nature of these appointments. Furthermore, Comhairle na nOspidéal, the statutory body responsible for consultant appointments, has stated that it is undesirable to allow temporary consultants to become a continuing feature of the health landscape. Accordingly, a number of long-term temporary posts have been made permanent, for good reasons.

There are a number of other problems associated with continually employing additional skilled staff for short periods. That may yield results in the early stages but over the longer period it creates uncertainty for skilled staff with unpredictable short-term contracts. They are much more likely to go where there is a chance of permanent employment and therefore their skills will move with them.

I wish to comment on references in the report to the prioritisation of patients and I deliberately involved Dr. Tony Houlihan in the delegation today so that if the committee wishes, he may comment further on this aspect. It is a complex question. Ultimately, the decision to admit a person to hospital is the responsibility of the consultant concerned who must decide on the relative merits of each case. He or she must make that clinical decision based on experience and training. Urgent cases will always get priority over non-urgent cases and it is very difficult to interfere with this clinical judgment.

While the rate of progress in achieving the targets set out in the health strategy for the reduction in waiting times has been slower than anticipated, the targets remain as goals to be achieved. There is nothing imprecise or aspirational about them. All health hoards outside the eastern region now report that, in general, adults currently reported to be waiting more than 12 months and children reported to be waiting more than six months have either been offered treatment under the national treatment purchase fund, NTPF, or have conditions that are complicated or are outside the remit of the NTPF.

The Comptroller and Auditor General has commented on the fact that some hospitals were able to benefit more than others from resources received from the waiting list initiative. This reflects the fact that there were inbuilt incentives related to performance. In fact, some hospitals were not able to take up waiting list initiative funding because of capacity constraints. We learned during the early years of the initiative that allocating in proportion to the size of the waiting lists primarily was not a good solution. Quite deliberately, the 1998 review adopted a performance based approach and we continued that to 2003.

The existence of lengthy waiting lists is one manifestation of the capacity issues in the health service. Capacity was recently identified by the OECD as a particular factor in long waiting lists. The acute bed capacity problem in the hospital system has been well documented. The Government has accepted the need to provide additional acute beds and has decided to provide an additional 3,000 beds in acute hospitals by 2011. More beds have been already commissioned in this context, of which 253 are in the ERHA region.

The report points to a number of information system deficiencies at hospital level regarding the output attributed to the waiting list initiative. This is something the Department is conscious of and intends to address in the forthcoming health information strategy. For 2004 there has been a 100% increase in the allocation for information systems over and above the original allocation for 2003. The committee will be aware from previous hearings that this is a priority of the Department and one on which we can move urgently and actively in 2004. The Department has adopted a policy of enterprise-wide systems with a view to standardising information and the provision of significantly improved management information systems.

Waiting lists will continue to be an indicator of how the overall system is performing. It is important that the public, politicians, the media and the wider health system have access to information on where the pressures are in the hospital services. The Department already publishes information on its website showing the national and local picture and we would encourage hospitals to publish more detailed information so that patients and their doctors can make informed choices about their care. That issue is being addressed by the ERHA and the health boards.

Against the background of the health strategy commitment on waiting lists, the success of the national treatment purchase fund and the report of the Comptroller and Auditor General, the Minister for Health and Children decided in the context of the 2004 Estimates to give a significant lead role to the NTPF in tackling waiting lists in the future. This announcement heralded the end of the waiting list initiative in its existing format. A substantial element of the funding is now being included as base or core funding for those health agencies in recognition of the staff and resources that have been put in place over the years to support the increasing elective workload. Additional resources will be made available to the NTPF to target those waiting longest for treatment. Discussions on that matter are ongoing.

In conclusion, the Department maintains that given the four objectives set out for the waiting list initiative, it has been broadly successful in increasing the level of elective activity in acute hospitals and in achieving an overall reduction in waiting time. Without this additional elective activity supported by the waiting list initiative over the past decade we would undoubtedly be faced with much longer waiting times than currently prevail. However, I would not argue that any part of the health system is beyond improvement, so I welcome the conclusions and findings of this report as an input to our ongoing efforts in the health system to address waiting lists for a variety of health and personal social services. I assure the committee that the Department will work closely with the national treatment purchase fund and the relevant health agencies in continuing to identify improvements which can be made in this area.

Can we get permission to publish that report?

Mr. Kelly

Yes.

Mr. Lyons

The ERHA welcomes the report of the Comptroller and Auditor General and is pleased to have the opportunity to discuss the findings with the committee. I have provided the committee with a detailed opening statement which I hope will assist the members in their deliberations on the report. I propose to make a few brief summary points which are included in the statement I have submitted.

The ERHA has put in place a framework to implement the waiting list initiative in its region since it commenced commissioning waiting list initiative work in the second half of 2000. In that context it is interesting to note that the period examined by the Comptroller and Auditor General ranges from 1998 to 2002. The framework put in place by the ERHA consists of contracting with individual hospitals using strict commissioning criteria and the benchmarking of unit and marginal costs for individual procedures against comparative costs such as case mix, private sector prices and the national treatment purchase fund. Monitoring and reporting arrangements have been put in place to ensure that the waiting list initiative work commissioned has been delivered and differentiates between waiting list initiative work and core activity and between in-patient and day case work.

We also routinely validate the waiting lists and we place patients in nursing homes and other appropriate services outside the acute hospitals to ensure that acute beds are freed up and that patients are treated in the most appropriate setting for their care. Details of the various components of the ERHA's waiting list initiative framework are set out in the statement submitted. Critical elements of the commissioning process are the targeting of long waiters and the skewing of funding towards hospitals with a proven track record in delivery and available capacity. This has struck an appropriate balance between addressing the needs of long waiters and the capacity of the hospitals to deliver on waiting list initiative work. As a result, the introduction of perverse incentives for maintaining long waiting lists has not arisen in the region.

In addition, the ERHA operates a policy of supporting hospitals with their waiting list initiative implementation plans, including recovery plans in cases where targets are not being met. However, in the event of a hospital not achieving its targets, the ERHA has decommissioned the work contracted for and transferred the funding to other agencies who have the capacity to deliver. In implementing its strategy on the waiting list initiative, the ERHA is working closely with the Department of Health and Children to increase capacity in the region. This is particularly relevant in the case of bed capacity in the acute sector and in regard to step down and rehabilitation places for persons who have completed the acute phase of their treatment.

The capability of service providers in the region to deal more effectively with waiting lists is constrained by bed capacity, which is inadequate to meet the demands for elective work. Other constraining factors in the region are delayed discharges from acute hospitals, changing demographics and the impact of referrals from outside the eastern region, which reduced the bed availability to residents from the region to below the national average as well as artificially increasing its waiting lists by about 20%. The high occupancy levels of up to almost 100% in acute hospitals in the region is another constraining factor, as is the impact of emergency admissions on elective work, which accounts for 20% of admissions to the region's acute hospitals on a consistent basis.

Despite those constraints, since the authority first commissioned waiting list initiative work in 2000, and, as the Comptroller and Auditor General said, up to September 2003, there have been improvements in the authority's performance and the service provided in the region. For example, total elective activity in the region increased by 34% to 54,176 cases. Emergency activity increased by 20%. The total number of long waiters in the target groups was reduced by 46.3% when the number reduced by 3,700 cases. The total number of long waiters in all specialities was reduced by 36% when the number reduced by 3,750 cases. A total of 382,000 cases were treated in acute hospitals altogether, of which approximately 24,373 were waiting for treatment. That represents 6.4% of total cases treated in the acute hospitals in the region.

When the impact of referrals from outside the region, which represent about 30% of all patients, and the fact that the reporting of day cases has always been a feature of the authority's reporting arrangements is taken into account, the percentage of persons waiting in the target group could be reduced from 70% to 39%. In addition, there is scope for discussion about the average waiting times referred to in the Comptroller and Auditor General's report. Fifteen months and 8.9 months for adults and children respectively have been referred to, but that relates to a cohort of patients who make up just 8.3% of total activity in the acute system. In that context, in 2003 almost 270,000 patients in the region accessed selective treatment very quickly, compared to 24,373 waiting more than three months. In addition, some of the patients waiting in those time bands are not medically fit for surgery and in that regard there is a need to address such issues as criteria for suspension or removal from waiting lists and the introduction of the unique patient identifier to avoid persons being on several waiting lists and facilitate their validation. That is currently being piloted and the evaluation should be completed during 2004.

As regards the effects of the waiting list initiative on in-patient work and core elective activity in the eastern region, the reduction of in-patient activity is directly linked to a shift in day case work in line with the national health strategy and international best practice. That has been mentioned by the Secretary General. The increase in day case work in the region is significantly greater than the reduction in in-patient elective activity. Since March 2001, overall elective activity increased by 34% in the region. I assure the committee that we will continue to work with each of the service providers in the region to ensure that long waiters are targeted and that waiting list initiative funding is ring-fenced and used for the purposes for which it is intended. We are also committed to working closely with the national treatment purchase fund, as we have since its introduction in the middle of 2002. While progress may have been slow initially in the eastern region in the referral of patients to the national treatment purchase fund, there were very good reasons for that which we might discuss during the session. There has recently been considerable progress and improvement in the referrals from the eastern region to the national treatment purchase fund. I trust that the statement which I have submitted will help the committee in its deliberations.

Thank you. Can we publish that statement?

Mr. Lyons

Yes, and the detailed statement if the committee so requires.

Mr. Kelly, the hospitals were to set out proposals on how they would use the funding and the proposals were agreed by the Department. Despite that, the Department did not ensure that the proposals from the service providers were directly targeted at the provision of treatment for long-waiting patients. In hindsight, was it a mistake that there was no direct targeting of that huge sum of €290 million on hospitals with long waiting lists?

Mr. Kelly

To answer the question I must put it into context. In the acute hospital system, year on year, there are approximately 2 million out-patient attendances, 1.2 million attendances at accident and emergency departments and 1 million in-patient treatments. The objectives and establishment of a waiting list initiative was against a background when the build-up in waiting lists and time in the system reflected an imbalance between the demand for services and the supply of beds available. It was intended as a solution to a problem that had built up over time, as I set out in the statement, because the demand for elective surgical procedures grows as new procedures are developed and the capacity to treat them increases daily. The imbalance that was there in 1993 has grown ever since.

I made it clear in the statement that four objectives were set for the waiting list initiative. There was not just the single objective of addressing long waiters specifically. The four objectives were achieving a significant reduction in the number of public patients awaiting elective procedures; increasing the number of persons receiving elective procedures; reducing the times persons are waiting for elective procedures in the target specialities to the limits specified; and improving the management of elective procedures, waiting lists and waiting times. It is reasonable, in the context of applying the funds made available to address the objectives of the waiting list initiative, that health boards and hospitals did that in a way which addressed the four objectives set and not simply one.

If we simply applied funding to addressing long waiters at a given point in time, the result would be that one would have a new cohort of long waiters. The steady State system is producing a waiting list and time. If one is to make ongoing inroads into that, one must bring up the level of elective activity and keep it up in addition to addressing the plight of those on the waiting list in the long term. I do not see it as a mistake in hindsight. I see that four objectives were set and addressed.

With regard to out-patients, it was calculated that, for every ten people waiting for elective treatment, four were waiting for an out-patient appointment to get on the list. Would Mr. Kelly agree with that figure?

Mr. Kelly

I do not know the basis for that. I do not have the exact figures with me today. There is certainly a problem in the health system regarding capacity for out-patient appointments. However, I make the point again that 2 million out-patient attendances are catered for in the system currently. Once again, that area was examined in the context of addressing the overall capacity problems in acute hospitals, specifically in the context of the health strategy. The principle was adopted that development of out-patient departments would be made part of the agenda in developing acute hospital sites. We will attend to that as we get the opportunity.

In the Eastern Regional Health Authority area we have very long waiting lists for people hoping for an out-patient appointment to get onto that waiting list. Would the problem not be much greater in hospitals that already have extended in-patient waiting lists?

Mr. Kelly

The point I am making is that there is a capacity issue on the throughput of out patient attendances. Certainly, if that capacity was dealt with without also dealing with the capacity restraint on the in-patient side, it would not make much sense.

On a final point, 20% of hospital beds are reserved for private patients where it has been suggested that the waiting time for private patients is not an issue. Does the Department keep any record of the waiting lists for private beds in hospitals?

Mr. Kelly

I do not have specific figures on the waiting lists for private beds, but the business of the Department of Health and Children is to set policy and the policy on the public-private mix in the public hospitals is that the current ratio should be 80:20. On a practical level, when I discuss this with hospital managers who have responsibility for operating this with CEOs of health boards, I find there are issues in managing that balance. It is not a straightforward matter because, as I have pointed out in the statement, emergency admissions, which count for 70% of admissions in accident and emergency departments, will always gain priority over elective work in hospitals. That is due to the nature of the medical problem those people have. Also, two thirds of private patients in acute hospitals arrive through accident and emergency departments. When one overlays that on the managing of the 80:20 balance, it reflects the fact that a higher proportion of the population, 50%, are now covered by private health insurance. With the proportion of people who arrive as emergency cases in hospitals it is inevitable that they will gain access as emergencies and that they will occupy places in the hospital.

Does that not indicate that we have a two-tier health system for those who can pay and those, on the public system, who cannot afford to pay? If one is in the private health system one is automatically guaranteed a bed, whereas in the public system one is waiting for 12 months and more.

Mr. Kelly

The point I am making is that there are two separate parts to the system in that there is a private system to which those who have insurance cover have access, quite apart from their access to the public system. In that sense, there is a two-tier system. Within the public system one's insurance cover as a public or private patient is not a factor. If one arrives in an ambulance at an emergency department, whether one is a public or a private patient, if admission is needed that will be gained. Furthermore, 70% of admissions arrive that way, ensuring an uncontrollable factor in the issue. It is a fact that 50% of the population are covered by private health insurance, which means they arrive at emergency departments and if they need a hospital bed, whether or not they are insured will not be a determining factor in whether or not they get a bed.

Those may be normal medical procedures. In a non-emergency in the private system, the absence of a bed does not seem to be a problem. However, in the public system, for a normal medical procedure, it would be a problem — one would have to wait.

Mr. Kelly

The private system does not deal with an emergency workload, which is the difference, in fairness. In single specialty hospitals, of which we have a number, that are not on emergency "take", of which Cappagh Hospital would be one, as it deals with orthopaedics, or in private hospitals that do not take emergencies, one can exactly plan activity and manage it with precision. That is not the case in public hospitals which are taking 70% of their admissions as emergencies.

I thank the officials from the Department of Health and Children for visually demonstrating what a waiting list looks like.

Perhaps Mr. Kelly could respond to a few observations on the value for money report. The waiting list initiative was introduced in 1993 and is now in its 11th year. It was initially seen as a short-term initiative, which begs the question of how long a short-term initiative should be. For the first half of its existence it was not seen to be very successful at all. In fact, in the targeted group the numbers increased significantly until 1998 and I have noticed that a lot of Mr. Kelly's statistics on the decrease are from 1998. However, if one takes the year 1993, when the initiative was introduced as the benchmark and 2002, when the value for money report was compiled, in the targeted group there was no significant decrease in numbers. The decrease since then, in 2003, is, I suspect, only a marginal decrease on the 1993 figures. There may be a number of factors to explain that, such as the initial funding being subsequently lowered. It then decreased until 1998, when it started increasing. Perhaps the greater amount of money was having more of an effect from 1998 onwards. Nevertheless, even from 1998 to 2001, the decrease in the targeted group was just in line with the decrease in general waiting lists.

There are questions about the first eight years of this initiative and its general effectiveness. There are further questions about the ability to measure value for money. That can be examined in a number of areas, first of all the differences between the different procedures — why some increased and others decreased — the differences between health board areas and the differences between hospitals, on which I will ask specific questions as I proceed.

Have my remarks been a fair interpretation of the value for money report and the problems, as opposed to the benefits, which have been portrayed in the statement?

Mr. Kelly

It comes back to whether we accept that there were four objectives set in this initiative and that in the allocation of funding, and its deployment and use, it was a legitimate exercise to address all four targets. The initiative was not exclusively established to address target specialties. It was established to address four distinct objectives which I have set out for the Deputy. One of those, very deliberately, was to generally increase the level of elective activity in the acute hospital system. Another was to address the target specialties and waiting times. A large part of my argument is that in all of the documentation describing the scheme, we have been quite clear that this was addressing four separate objectives.

In respect of different performances and different impacts over periods of time, it is a fair comment that during the early years of the initiatives there was some impact but it was not very significant. That reflects the fact that we are not dealing with a static group of people, rather there are stops and flows in which there is an outward flow every year and an inward flow.

We are trying to ensure we deal with more people every year than join the waiting list or wait longer than 12 or six months. That is the dynamic that is at work, particularly from the year 2000, and is also related to the general level of funding that was flowing into the health system in 2000 and subsequent years. There was also significantly increased funding for the waiting list initiative, the impact of which we can see. That is clearly shown in the report where the improvement is demonstrated from 2000.

Mr. Kelly referred to the four benchmarks he was using on the introduction of the initiative. The value for money report questions the use of the number of people as being the sole or best indicator in respect of waiting lists. There is the aspirational target of a waiting time of 12 months for adults and six months' for children for these procedures. However, when the value for money report was being done, the average waiting times were 15 months and 8.9 months, close to nine months, respectively. Given that this was the average figure, can the initiative be seen to be a success? Surely the delivery in terms of actual waiting time for the individual citizen should have been the scope for this initiative.

Mr. Kelly

Ultimately, what is important to an individual is that he or she does not have to wait for a service, whatever service it is. From an individual's point of view, that is the most important consideration. That is why, particularly in the context of the analysis of this that was done in preparing the health strategy in 2001, we spent a lot of time, both in the consultation process and in our own discussions within the Department and with hospitals and health boards, analysing further what needed to be done to improve performance regarding waiting lists and waiting time. It is out of that analysis that the idea of the national treatment purchase fund emerged and that the fund was put into operation during 2002. I accept that one can take any point in time along the spectrum of this initiative — and December 2002 is one — and say that at that time matters were not good or whatever. What I am saying is that as of September 2003, other than in the eastern region — and Mr. Lyons will comment on aspects of that — that target for adults of 12 months and for children of six months is being met.

It is not being met for all procedures. We know from the value for money report that the figures for ophthalmic surgery, urology and general surgery were higher in 2002 than they were in 1998 and the 1998 figures were higher than those for 1993. What are the conditions that have brought about an increase in waiting lists for these procedures? Mr. Kelly might also outline the individual procedures involved under the heading of general surgery.

Mr. Kelly

I personally cannot go into it. If the committee wants a technical description of the procedures involved in general surgery, I could, with the committee's permission, ask Dr. O'Holohan to comment on it. As to the factors that give rise to an increase in one area, in any particular period there may be a concentration of additional resources in one area, for example, additional consultants are appointed in one specialty. In other areas it may be that the rate at which people are coming on to the waiting list increases because, for example, the rate at which they are being seen at out-patient departments or are being referred. There is a dynamic in this from year to year. From the Department's point of view, the handle we get on this year on year is when we have our discussions with health boards on their service plans for the year. Waiting lists would always be an issue for discussion at those meetings. In the context of the 2004 service plans, in the next number of weeks, once the respective health boards have adopted service plans and submitted them to us, we will be meeting them and these are some of the questions we will be putting to them in relation to the outcome for 2003 and how they intend to address that in 2004.

Let me move on to another area. Mr. Kelly has already alluded in his presentation to the fact that the waiting list initiative led to the funding of temporary consulting and nursing posts over the course of the year, which was welcome, many of which were subsequently mainstreamed. There is a question in the value for money report that this might have led to a potential loss of flexibility in the administration of the waiting list initiative funds. Is that a fair comment? Was there, in effect, a loss of flexibility because of the temporary nature of these points and their mainstreaming and subsequent relationship with the waiting list?

Mr. Kelly

In an ideal world, if one creates a pool of discretionary funding to be applied to a particular problem, one does not permanently appoint people in a way that lessens one's flexibility. It is a fair to say that lessened flexibility. The question that has not been addressed is whether there was an alternative. There is no particular comment on that in the report. However, I would offer a comment on it. I have made the point already in my statement. In today's employment market one cannot ask people who have trained as medical consultants and who are trained in the more specialised areas of nursing, to hang around and wait to see whether something will pop up on the waiting list initiative next year and, if it does, to turn up and take a job. People do not do that. In the areas we are talking about, the staffing that has been put in place is of two kinds, clinical and non-clinical. Clinical staffing comprises medical and nursing people principally. To confirm the Deputy's point, over a ten or 11-year period with additional people employed — and it is a matter of fact that we need people, pairs of hands, skills to do additional surgical work — it made sense to put those into place where there was a continuity of funding coming through year on year and where one of the main objectives of this whole initiative was to increase the ongoing level of elective activity in the hospitals. If the objective had been solely to address a different group of patients every year, that would not make sense. However, in a context where one of the main objectives is to increase the level of ongoing elective activity generally, it does make sense. The other group of non-clinical posts comprises the people involved in waiting list management and bed management and discharge planning in the hospitals. Again — and it is reflected in the report — there are clear benefits to having those people actively managing the throughput of patients in the hospital with a view to gaining maximum efficiency from the available bed stock and, the point has been acknowledged in the report, that is in evidence in the hospitals that were visited by the Comptroller and Auditor General in the course of his exercise.

Is it not also true that the use of the waiting list initiative funding did not specify that the staff were required primarily for the patients waiting longer than the target maximum waiting times? In a sense, while there was a value in the additional staff within the health service in particular and for waiting lists in general, the funding was not used exclusively for the waiting list initiative and the effect was not predominantly seen in the waiting list initiative.

Mr. Kelly

The waiting list initiative is a set of arrangements put in place to address four objectives I mentioned earlier — long waiters, waiting times, elective activity generally and, particularly, increasing the level of elective activity in the acute hospital system. In that context I would not agree with the Deputy.

It is a point from the value for money report.

Mr. Kelly

I would not agree with the point made in the report either. I do not accept it.

I have two more questions. The waiting list initiative has been more or less integrated into the national treatment purchase fund, but it will still exist in some form. What form will that be and how will it be targeted in the future?

Mr. Kelly

The waiting list initiative?

Mr. Kelly

We are talking this through in the Department at the moment so I cannot give a definitive answer. It is clear that the funding, which has become part of core base funding in the health boards, about €23 million of the total allocation for the initiative in 2004, has been allocated to the relevant health boards on the basis that it is necessary to continue with the level of activity that the posts and so on that are in place will support. As regards the balance of that funding, we are currently in discussion with the management of the national treatment purchase fund, and will discuss with the health boards when we see them regarding their service plans, how the balance will be struck in terms of allocating that funding between health boards and the national treatment purchase fund. However, it will involve an increase in the allocation to the fund during 2004.

This is not the first co-ordinating piece between the operation of both initiatives. For example, the assistant secretary of the hospitals division in the Department is a member of the steering group for the national treatment purchase fund. Similarly, there is liaison with chief executives and other representatives of health boards on the steering group. So, the initiative and the fund have operated with a degree of co-ordination over the last two years. We are now moving on from that and are, in part, informed by the analysis in the report and, in part, by our own analysis, having seen the success of the fund in contracting with the private system, and to some extent with the public system. They have gained that additional activity level and, in particular, have developed this transparency between funding and output. In 2004, we are putting them in a lead role in this respect.

My final question also relates to Mr. Kelly's presentation when he talked about the Department improving its information systems for collecting statistical data for comparative purposes. He did not seem to respond to the suggestions made by the Comptroller and Auditor General in the value for money report, which referred to the need for new and different indicators that might be more effective in measuring the value for money aspect. The Chair has already sought statistics on private hospital patients but there is also the question of waiting times for outpatient facilities for consultants. Does the Department intend to act on these recommendations and will they form part of the review of new information systems the Department will have in place in future?

Mr. Kelly

Yes.

In both areas?

Mr. Kelly

I have not commented on it because at this stage we have not got to the point of specifically setting out what the IT developments will address in 2004. We know broadly what the systems will be but not what reports they will produce. There is an ongoing engagement both by the Department and the health boards concerning a suite of performance indicators on the health system. We have developed a set of performance indicators and are applying them in many areas at present. We will certainly address the recommendations that have been made here in that context, in looking how we could build the indicators in this particular area.

Mr. Purcell has a point of clarification.

Mr. Purcell

I do not think we should get hung up on the four objectives and I am not really taking issue with what the Accounting Officer has said. However, I think it is fair to say on the basis of documentary evidence — and that is what an audit has to rely on — that these did not emerge until after the review group reported in July 1998. They emerged in a clear fashion in the guidelines issued by the Department in 1999 and 2000. Even in the set of guidelines that were sent to the chief executive officers of health boards and hospitals in 2000, the Department did point out in a covering letter that the overall objective of the initiative was to ensure that the target maximum waiting times were not exceeded.

I think it is common cause between us that from around 1999 and 2000 onwards, the management of the waiting list initiative improved immeasurably and, together with the effect of the treatment purchase fund, it is having a real impact. On the basis of what I have seen in carrying out this review over quite a long period, it was not so well focused prior to that time. Perhaps that puts into context both what I said earlier and what Mr. Kelly and Mr. Lyons have said.

I thank the officials for attending the committee. I have listened to the discussion so far but I want to understand the big picture before getting into the details. In that regard, I want to address a few questions to the Comptroller and Auditor General, who wrote the report. Did the taxpayer get value for money from the €172 million that was spent from 1998 to 2002? That is the essence of what we are here to discuss.

Mr. Purcell

To reiterate what I said a few moments ago, the taxpayer got better value for money in the later period than during the earlier period. Having said that, given the initiatives put in place in the last year or two and those that will be put in place in the coming years to measure performance — the appropriateness of the type of measures that are being put in place were indicated to the committee by Mr. Lyons — we will be able to answer the Deputy's question more definitively.

This brings me to my basic starting point and I hope the Comptroller and Auditor General will not mind me putting it this way; I presume one of the reasons this report was commissioned was to establish whether or not the taxpayer got value for money. We do not know the answer to that question, however. The Comptroller and Auditor General has spent 18 months trying to establish whether there was value for money, by producing a report for the Dáil. Yet, after 18 months of research work he now tells the committee that when new systems are put in place in the future he might be able to answer the question. I find that a strange starting point for this report, that the Comptroller and Auditor General cannot give us an answer after 18 months' work as to whether or not value for money was provided.

I have seen very good reports being produced by the Comptroller and Auditor General's office and when this one came out I read it with great interest. I looked forward with pride to see how my local hospital and region compared with others on a year by year basis, to see whether they were better or worse than other regions, and what mistakes were made. However, I cannot get an answer to the simple question of whether the taxpayer got value for money. What is the report's conclusion?

Mr. Purcell

That is a very general question.

It is a specific question. That is what the report is concerned with.

Mr. Purcell

I know, but everything is relative. Of course, better value could have been achieved. Certainly, some of the report's findings indicate where better value could have been achieved by better targeting and focusing and by addressing matters in a slightly different way. I think I have answered the Deputy's question in saying that in the latter years better value for money was achieved than in the earlier years, but more needs to be done. We like to operate to an optimum position but if the framework and procedures are not in place to measure whether value for money is being achieved, that in itself is a key finding. In a sense, however, many of those procedures are only being put in place now.

We spoke about targets. We had two targets: the 12-month maximum waiting time for adults, and six months for children. I would have thought that year on year, one would have specific targets for the number of procedures that had to be done in order to achieve intermediate reductions, taking into account the volatility of the waiting list. Those are some of the indicators but one cannot definitively make statements about value for money without having the appropriate measures in place. They are now being put in place and that is a key finding of the report.

Right, but I want to continue on these lines.

On that point, we can certainly give credit for the procedures put in place as a result of the report, which identified the huge anomalies that existed.

You have missed my point, Chairman. I sit here every week to consider, among other things, the appropriation accounts of every Department. The Comptroller and Auditor General audits those every year and signs a certificate to say that the income and expenditure is in accordance with a Vote of the Dáil. He also provides a conclusion and I would have expected one in this report. When people hire auditors — and especially when the Comptroller and Auditor General does the job — they expect a conclusion. I expected the report reach a conclusion that there was or was not value for money or that it was not possible to say.

I am beginning to get the impression that the essence of the report is that it is not possible to say whether there was value for money over recent years. The Comptroller and Auditor General said that recently there has been some improvement and that further improvement is possible if there are changes. If that is the case it should have been set out in the report as the conclusion. If someone gets a copy of the report from the Oireachtas Library or purchases it for €6 from the Government Publications Office, he or she will expect to see an outcome, that is, whether there was value for money, but will be none the wiser.

The purpose of this session is to ask the witnesses questions.

I am surprised the Chairman is trying to divert questions. We are here to discuss this seminal document and to address the details of it with the officials from the Department. Before I question the witnesses — if I am on my own on this, so be it — I want to be happy about the veracity of the report. I am asking questions to which I have not yet got an answer. What is the value of the report if there is no conclusion at the end of it? I am at a loss, Chairman.

Maybe the structure of these reports in the future should be different. We get a definitive report on the Appropriation Accounts but this value for money is vague. It is not easy to draw conclusions from it. I am none the wiser. I hope that in future when we get reports, there will be a conclusion we can put to witnesses. In this instance I cannot even say to officials from the Department of Health and Children if, based on this report, which is the result of 18 months' work by the Comptroller and Auditor General, their Department achieved value. I will move on.

One point Deputy, I am not——

Maybe the Chairman misunderstood me. I am just asking simple, basic questions.

I am not trying to divert attention. The Comptroller and Auditor General is well able to stand over his report. I wish to make that point clear, Deputy Fleming.

Mr. Purcell

There are a couple of issues. To cast doubts over the veracity of the document is inappropriate because the final document is sent to the Department and the relevant health boards to confirm the factual accuracy of the items and figures in it. There will always be differences of opinion about particular aspects of the report and where they are relevant and material, they are reflected in the report and the Accounting Officer or the chief executives of the health boards, as the case may be, have the opportunity at that stage to state them. If they are material, they will be included in the report to show both sides of an argument.

On the value of the report, that is for many people to judge. However, there is certainly a value in getting much of the data which was not there beforehand and presenting it in a public document for people to make up their own minds. As the Deputy said, he was able to look at the hospitals in his region to see whether they were good, bad or indifferent relative to others.

As to whether one can come to an absolute conclusion in a single line in the same way one does in giving an audit opinion in an audit report on accounts, it is not possible; it is as simple as that. The Deputy said there were no conclusions but I see conclusions at the end of sections two, three and four. If the Deputy wants to look at the conclusions, they are there. They are not in a single line as one would see in a set of accounts. I have studied the work of my counterparts in the developed world and they have not managed to do so either. If the Deputy can come up with a formula which would enable us to do that, I would be delighted to hear it through the committee or on an individual basis.

I want to come back on two points. I fundamentally reject the Comptroller and Auditor General's comment to a Member of Oireachtas Éireann that it is inappropriate to discuss the veracity of a report laid before Dáil Éireann. The Comptroller and Auditor General commences the report and sends it to the Department and to the Minister who lays it before the Dáil. The Dáil is entitled to consider or discuss the report and that function has been delegated to the Committee of Public Accounts. Its function is to discuss the report and to agree or disagree with it, to note it or to report on it to Dáil Éireann.

The Members of Dáil Éireann are not members of the executive staff of the Department of Health and Children or of the Comptroller and Auditor General's office nor are they the Minister for Health and Children. The Members of Dáil Éireann vote on this expenditure in the Estimates process each year and for somebody to suggest that it is inappropriate that we should comment on a report laid before the Dáil — a value for money report on expenditure voted by the Dáil — is not——

Deputy, I am the Chairman. The Deputy is totally misinterpreting what was said.

I wrote down what was said. The Comptroller and Auditor General said it was inappropriate to challenge the veracity of the report.

I am not sure what is the Deputy's agenda today.

My agenda is——

The agenda is to discuss the report.

The Comptroller and Auditor General specifically said it was inappropriate to challenge the veracity of the report. I have made my point and the transcript will show——

The record will show, Deputy Fleming——

The record will show whether those words were used. I wrote them down.

What was the suggestion about having an agenda, Chairman?

My agenda is black and white. As a member of the Committee of Public Accounts, my agenda is to——

We are here to study this report.

——take my responsibility seriously, to study the report and, when I have studied and understood it, to put it to the witnesses. As of now, I have not got to that stage. I have not studied it. I did not suggest there were no conclusions. There are several conclusions throughout the report but the overall conclusion, which would be helpful to Dáil Éireann as to whether there was value for money for the taxpayer, is not addressed. Several points of detail are addressed but the big question is not. I will address the question of getting out the data in the report, but I will move on.

As a member of the Committee of Public Accounts, I consider the following question, which I do not see addressed in the report, important. Was the money for the waiting list initiative spent in accordance with the directions of Dáil Éireann and the purpose for which it was intended? That question is directed to the Comptroller and Auditor General who has written the report. If it was not, it is a serious situation and if it was, I would like to know because I did not see it in the 53 pages of the report. I consider the starting point as being whether money was spent on the purposes for which it was voted. That is the starting point for every expenditure discussion.

Mr. Purcell

That question is addressed at various stages in the report, including in paragraphs 2.32 and 2.35. There is a lack of traceability, but, as I said in my opening remarks when introducing the report, while the targeted money appeared to have been applied to activities designed to achieve the general aims of the initiative, there was a lack of traceability in the hospitals we visited as to how the funds were used.

That is the reason I asked the question. The Comptroller and Auditor General mentioned specific hospitals in paragraphs 2.32 and 2.35 and said there were no effective systems in place to distinguish the expenditure. As a member of the Committee of Public Accounts, I was concerned as to whether this expenditure was misappropriated and spent on some purpose for which it was not voted. The Comptroller and Auditor General's opening statement places a completely different emphasis than what is in the report. He stated it "appears to indicate". I am at a disadvantage because I do not have a copy of the opening statement and I am merely recalling what the Comptroller and Auditor said. It is not definitively stated in the report and in his opening statement, the Comptroller and Auditor General said it appears to indicate it was generally spent on the purpose for which it was intended. Perhaps he will read what he said because I do not have a copy in front of me and it might help to answer the question.

Mr. Purcell

I do not use an absolute statement; I use speaking notes. That is why the statement is not available. To say that varies from what I said in my opening statement is not true. In paragraph 2.45 I state that visits to hospitals indicated that while waiting list initiative funds appear to have been applied to activities designed to achieve the general aims of the initiative, clear traceability was largely lost. That is consistent with what I said, Chairman. I cannot say anymore than that. It is also in the report.

A number of hospitals were visited, but that does not cover the entire fund. Were the funds spent in accordance with the direction of Dáil Éireann? Is there a definitive answer to that question?

Mr. Purcell

There is a definitive answer in that they were applied for the general purposes of the waiting list initiative. That is what appeared to be the case. However, it is difficult to be definitive because, as stated in my report, hospital accounting systems did not track the application of the funds. It is as simple as that.

The annual appropriations accounts for the past ten years certify and specifically state that the funding, on a year by year basis, was in accordance with the vote of the Dáil.

Mr. Purcell

I can absolutely stand over that because the Deputy will be aware that once moneys which have been appropriated are used for the purposes set out in the ambit of a Vote, I am enabled to state that they were used for the purpose for which they were granted. The subheads are a sub-division of that. However, the overall legal position is that they are used for the purposes set out in the ambit of a Vote.

I am glad to hear that because reading the paragraphs to which the Comptroller referred I, as a member of this committee, was getting the impression that this money was not voted or used in accordance with the instructions of Dáil Éireann. I am happy that the Comptroller and Auditor General has had no overall difficulty with the overall report of the Department during the past ten years. I was concerned that there was an implication that the money was not spent in accordance with the vote of the Dáil but the Comptroller and Auditor General has confirmed that this was not the case. I am pleased by that because it would be a serious matter for the accounting officer if that was not the case. I wanted to establish the position before questioning the accounting officer.

I have considered the report. We are concentrating on the €172 million that was spent over the five years. I am aware of the difficulties in obtaining accurate information but the report does not indicate the number of procedures that were carried out as a result of the provision of that funding under the waiting list initiative. I had expected a value for money report which would state that €172 million was spent and that X number of procedures were carried out at a particular average cost, which was either good or bad value for money. That was my principle disappointment in reading the report. It does not provide information regarding the number of surgical procedures carried out with money provided from the fund on an annual basis or on a health board basis. Such figures are not provided at all. I do not know how we can reach a conclusion in light of the fact that there is no indication of the number of procedures carried out.

The Comptroller and Auditor General was obviously provided with some figures by the health boards and he felt that they were not reliable. We accept that. However, the report does not contain any figures relating to the output or the number of procedures carried out. The only comment is that the overall number on the waiting list dropped from 14,100 to approximately 9,000. That figure covers tens of thousands of operations each year and the tens of thousands of people who go on to or come off the list.

Mr. Purcell

There is a simple answer to that and the Deputy alluded to it. We could not rely on the figures because there were not reliable records in the hospitals in which these procedures were undertaken. It is clear that many elective procedures were undertaken but the extent to which they were paid for under the waiting list initiative targeted funding was difficult to establish. My view in that regard is reinforced because the Department attempted to arrive at some figures. However, there are significant differences between the figures it supplied in April 2002 and those it will report this month. This bears out the point.

Auditing is all about trying to establish firm figures in order to put that information before the public and the committee. I return to what I said earlier, namely, that we were not able to rely on the figures produced in the hospitals. Different hospitals used different bases for estimating the number of procedures carried out. In such circumstances, I was not in a position to produce the information to which the Deputy referred.

I accept that and I preface my comments by stating that the Comptroller and Auditor General's report refers to the inconsistency in information. Obviously, however, the health boards provided their best estimates of the number of procedures involved, which the Comptroller found difficult to verify and he decided not to include the relevant information.

Does Mr. Lyons wish to comment on that matter?

Mr. Lyons

I wish to provide the information we possess in respect of the total number of procedures carried out under the initiative which might be of help to the Deputy in terms of benchmarking.

To what years does the information relate?

Mr. Lyons

It relates to the period from 2000 to December 2002.

Does Mr. Lyons consider that information reliable?

Mr. Lyons

Yes.

We are being told that there is some reliable information available. However, none of it is contained in the report. If Mr. Lyons states that his information relating to the numbers on the waiting lists and the number of procedures carried out on a year by year basis is reliable, I will take his assertion on good faith.

How can we be sure that it is reliable?

I take Mr. Lyons's word, provided in front of this committee, in good faith. Is the Chairman suggesting that——

No, I am just clarifying——

I accept Mr. Lyons's word in good faith. The Comptroller and Auditor General must have some view about the sum of €172 million. Did it pay for 10,000, 50,000 or 100,000 procedures? Neither Members of the Oireachtas nor the general public know the answer to that question. The Comptroller could have taken the information provided, qualified it and given a plus or minus range, based on accuracy. We would then have been able to identify a range of procedures that may have been carried out. I have no idea of the number of procedures, to the nearest 10,000, that were carried out.

We are going to have difficulty concluding our discussion on this report. I know how much it cost but the report provides no information regarding the number of procedures involved. Some of that information might be available and if we estimate it to the nearest 10,000 we might then gauge whether particular procedures cost €1,000, €2,000, €5,000 or €10,000.

Mr. Purcell

When discussing the reliability of figures, I refer to the procedures in, for example, the Midland Health Board area, with which the Deputy will be familiar. In April 2002 it was reported that 867 procedures were carried out under the waiting list initiative in 2000. In January 2004 that figure has been reduced to 560. Those figures are, therefore, fairly unreliable because there is a large percentage difference between them. In the case of the Mid-Western Health Board for 2000, in 2002 it was reported that 991 procedures were carried out under the waiting list initiative, while this month that figure has risen to 1,724. In the round, it would be difficult to give overall figures in which one could have confidence.

I take the point Mr. Lyons made. When the Eastern Regional Health Authority was established — I acknowledge this in my report and state that some of the other health boards could follow its example — it arrived at figures which are consistent. However, having visited some of the hospitals I am aware that while the figures provided by St. James's hospital were fairly reliable, the position at St. Vincent's was somewhat different. Until recently, Tallaght hospital was not in a position to distinguish between day cases carried out under the waiting list initiative and other cases involving elective surgery. There were problems there and in that situation I might have been accused of misleading the public and the committee if I were to put those figures into a report.

The report should be helpful to the reader and no information is completely unhelpful because one does not know where one stands. While acknowledging the questions over the available information, there were two reasonable options, one of which was to include the information and qualify it by stating they were best estimates. However, the Comptroller and Auditor General will not stand over them because they are not verified. A more direct approach would have been not to provide information and be upfront. We do not have a concept of the number of procedures and we cannot conclude whether there was value for money based on the procedures carried out. Perhaps the report should have been shortened because, due to inadequate information in the system, it is not possible to conclude whether there was value for money. We only know the cost.

Estimates have been provided with suitable health warnings on other occasions regarding upcoming matters that may or may not have been accurate. This is a matter relating to the past for which best estimates could be provided with a suitable warning. At least we would know whether 1,000, 50,000 or 100,000 procedures were carried out. The Chairman is none the wiser in this regard and I do not know how we can conclude the report.

Has the Deputy questions for the principal witness?

Yes. Is the Chairman cutting short my questioning of the Comptroller and Auditor General on the report?

Other members are offering to ask questions. There is a time constraint.

I refer to paragraph 2.4 on page 17 of the report, which covers how the funding was allocated. The same point is made on page 18. Paragraph 2.4 states it was "recommended that the (smaller) second phase of the funding would be awarded to service providers with the best performance record". The Comptroller and Auditor and General states on the following page that the Eastern Regional Health Authority collated information about the use of the funding. Information is in the system that could be used for the allocation of funding and it must have been checked to some extent. The Comptroller and Auditor General refers to that information but did not include the number of procedures. It would have been helpful if a range of best estimates had been included because we do not know the number.

Paragraph 2.18 on page 21 refers to the current pattern of allocating funding. It states that significant amounts of initiative funding are being directed "on a more or less permanent basis to the service providers that have consistently succeeded in reducing their reported number of long waiting patients and maintaining this record". The Comptroller and Auditor General is happy to refer to the consistent record of reducing patient numbers but, if he is happy to do so and the Department is happy to rely on that, it would have been helpful to have given the committee some of the benefit of that issue.

I refer to paragraph 2.42 on page 27, on which I would like the Comptroller and Auditor General to comment. The paragraph states that the decline in elective in-patient activity treatment arose because of the number of emergency admissions and the lack of step-down beds. However, another significant reason is that elective day admissions increased significantly during the period.

The Secretary General stated in his opening contribution that, in 1998, the number of in-patient procedures was 537,000 and out-patient day care cases was 270,000. In other words, the split was 63%-37% in favour of in-patients. However, he stated that, in 2002, the number of in-patient procedures was 556,000 while the number of day cases was 401,000. The split was 58%-42%, which is a major improvement. That is a significant reason there was a reduction in in-patient treatments and that should have been reflected in the report.

Mr. Purcell

I am in agreement with Deputy Fleming for once. Paragraph 2.42 states: "Apart from the increased treatment of patients on a planned day case rather than an inpatient basis as a result of advances in treatment the decline in the elective inpatient treatment in hospitals may be attributable to..." those two other factors. I make it clear that the primary factor is the increase in the treatment of day cases. I do not see an inconsistency.

The Mater Hospital gets a raw deal on page 20 of the report. The Comptroller and Auditor General refers to divergence in the Dublin hospitals and states:

The Mater Hospital reported the biggest target group (over 1,600 long waiting patients) at the end of 2001 — up 4.5% from the end of 1997. Despite this, its share of the waiting list initiative fund fell from 15.5% of the total in 1998 to 9.5% of the total in 1992.

The implication is that, while the waiting list increased, the hospitals proportion of the funding was decreasing. The figures quoted by the Comptroller and Auditor General are wrong.

Mr. Purcell

These figures were put to the Department and it did not have a problem with them. There were capacity problems in some hospitals and they were unable to take their fair share of the waiting list initiative funding. The Accounting Officer mentioned that in his opening statement and that is the primary reason that happened.

I understand, but appendix B of the Comptroller and Auditor General's report states that €1.2 million was allocated to the Mater Hospital in 1998 from a fund of €15.224 million, which is 7.9%, not 15%. A sum of €3.647 million was allocated in 2002 from a fund of €43.806 million, which is 8.3%. The arithmetic is wrong if one goes on the basis of the appendix. The paragraph does not correspond with the appendix and, because of the mistake in calculations, the Mater Hospital has been done down unintentionally by the Comptroller and Auditor General. I would not like the hospital management to feel it received reduced funding, because it had increased during the period. The report states otherwise and the wrong impression might have been created for the hospital.

Mr. Purcell

I can certainly come back to the committee on those figures and, if there is an error, I will acknowledge it but it would be impossible to do it at this moment. I will get back to Deputy Fleming.

It is just in case it is interpreted as a reflection on the Mater Hospital.

Will the Secretary General explain the capacity problems at Tallaght Hospital because it was unable to take up waiting list initiative funding in 2002? Its waiting list at the end of 2002 comprised 1,440 people, of which 885 were in the target group. It is extraordinary that such a new hospital was not in a position to avail of the funding. These circumstances might be explained.

Mr. Lyons

The report indicates that there were fluctuating performances by individual hospitals in regard to waiting list initiative work over the period in question, including Tallaght Hospital. The Deputy will be aware that Tallaght is a new hospital which has been gearing itself up to full capacity since its establishment.

Apart from physical capacity problems in the acute hospitals, there are practical ongoing issues that compromise the ability of hospitals such as Tallaght to do waiting list initiative work to the level that perhaps they could do. For example, Tallaght had been experiencing a high number of delayed discharges. These people had finished their acute phase and were delayed in being discharged. The hospital had increased activity coming through the accident and emergency ward. The winter vomiting bug hit the hospital and it has ongoing high levels of emergency activity.

Having said that, there has been a significant improvement since the end of 2002. Over the entire period from March 2001 to September 2003, the period during which the authority related to Tallaght Hospital, there has been almost a 30% reduction in the overall numbers waiting. There has been a 61% reduction in long waiters and a 58% increase in the number of patients waiting within the Department of Health and Children target times.

Given that Tallaght has capacity constraints and 885 people were waiting longer than the target time, has each of these people been offered the option of the national treatment purchase fund? If there are capacity constraints in the four large hospitals, it will not be possible to meet these targets in a reasonable period. While the Minister has made changes since then, I hope that, as a matter of priority, all patients in the four hospitals that exceeded the target time were offered the national treatment purchase fund option.

Mr. Lyons

A representative from the fund is here today. I understand that each of the people who were waiting were written to by the hospital.

Were they written to recently?

Mr. Lyons

Yes.

Mr. Pat O’Byrne

Tallaght Hospital has particular problems, some of which were referred to in regard to capacity. Approximately 400 to 500 patients were identified to us when we were set up and defined as the longest waiters in Tallaght. By the end of December, most of these patients had been treated, with the exception of a few. Part of the process was that the hospital wrote to patients and offered the option of NTPFs.

While I have a number of questions, I do now want to go back over the ground covered. There is a public perception that there is a black hole in the health services and that all these initiatives, although good in themselves, are a let-down for many citizens. We do not have to say it at this meeting for most people to understand that this is the case.

My first question is for the Secretary General. In so far as the so-called ring-fencing of the waiting list initiative is concerned, in other words, where funding was corralled to do a specific job, does the Secretary General have in his possession all the information needed by the Department to be able to ascertain whether this was an extra in each hospital? Was the initiative used to help the people who were crucified with pain for two, three or four years or was it involved in general hospital administration as such?

Mr. Kelly

I must rely on the reports I receive from the managers and chief executives of health boards and the Eastern Regional Health Authority. Year on year, a specific part of our joint discussions on the service plan for a particular board or ERHA would be concerned with what they have done — there is a review of their performance the previous year — in regard to funding they received for this purpose and what they plan to do with the additional funding allocated for the following period. Having said that, it is quite clear from the experience over the ten years of the initiative that an element of the funding which is put in place each year for waiting list initiatives forms part of the core base funding of particular hospitals run by health boards.

Would Mr. Kelly agree that this is something which did not begin yesterday or today?

Mr. Kelly

Yes. We are talking about a ten year experience with this particular initiative.

I am not saying whether it is right or wrong because I am not in a position to know that. However, given the checks and balances in the system where millions of euro are spent on behalf of Irish taxpayers, has Mr. Kelly, as Secretary General of the Department which has an important and pivotal role, the same or greater access to information than the Comptroller and Auditor General? Did the Department carry out in-depth investigations to try to obtain the answers contained in the value for money report?

Mr. Kelly

The methodology typically applied by the staff of the Comptroller and Auditor General's office — I have a lot of respect for the work they do — would bring a depth and rigour to an analysis of this kind where they can put trained people to work on it over a period of time.

Is Mr. Kelly saying that, from a methodology point of view, they would have done something that might not be normal practice either for the Department of Health and Children or the health board executives in the hospitals?

Mr. Kelly

I will let Michael Lyons speak for ERHA which has done a lot of in-depth analysis of different services, which is also the case for other boards. I will not make a general statement about what is going on in the boards. At Department level, we simply would not have the time or the expertise to engage with a question like this in the manner in which it is possible for the Office of the Comptroller and Auditor General to do.

Having said that, we did our own review of the initiative in 1998. I led an intense examination of the issues involved in the context of preparing the health strategy. There was a detailed analysis of the performance and the success or otherwise of the arrangements then in place. When I took up my appointment in 2000, I led a deep invigilation with the chief executive of each health board of performance on the waiting list initiative at that point and, in particular, focused on what they would achieve with increased funding during that year. The evidence of the increased funding and increased focus in the statistics for 2000 bear out that experience. The hospitals division in the Department has particular people who keep an eye on experience with the waiting list initiative. In the first instance, we rely on health board and hospital management to manage this responsibly, to take that funding, as we do with all earmarked funding, and use it for the purposes for which it is intended.

The bottom line is that, under the 1996 accountability legislation within which the whole service planning process works for health boards, the ultimate and overriding requirement that every health board must address is to achieve a break-even situation under total allocation. That requires them to employ some flexibility, even in relation to funding that is earmarked for a specific development by the Department in the letter of determination.

There is no absolute science that one can apply to tracking an amount of money which was given at any time. It forms part of the overall pool. However, by and large, it is used for the purpose for which it is allocated.

With all the money that has been spent on behalf of the taxpayer, and by any standard it has been a large amount, is it not a remarkable commentary on the system that, according to page 40 of the Comptroller and Auditor General's report — I am sure Mr. Lyons will comment on this — 1,300 people or 8% of those in the Eastern Regional Health Authority area are four years or more on a waiting list? Irrespective of what one might suffer from, four years or more is a long time. Are there 1,300 on waiting lists and, if so, what is the profile of people who must wait so long? Obviously, they have seen a consultant and have a bona fide case, or so it appears to me from the people who have contacted me over a period. Can Mr. Lyons throw some light on how it is that neither the national treatment purchase fund nor the waiting list initiative have been able to assist these people?

Mr. Lyons

The Deputy's last point reflects the position of the people he refers to in that the treatment purchase fund has not picked them up either. This raises the question of their profile and their suitability for elective procedures. In any waiting list there is a range of people who would be medically unfit, may not want to have surgery or whose social circumstances may dictate that they cannot avail of it. Some people defer surgery or may even be on a waiting list in another hospital, either in the region or elsewhere in the country. There is an issue as to whether or not the 8% should be included on the waiting list at all or whether there should be an agreed methodology which would involve clinicians who have the ultimate say in whether or not a person is referred to a waiting list or should be suspended or removed from a waiting list. There need to be some suspension criteria to enable decisions like that to be taken.

The average waiting time, as indicated in the report, refers to persons waiting over 12 months and includes longer waiters, such as the 4% and 8% referred to in the Comptroller and Auditor General's report. That does not take into account the numbers who access the system very quickly, usually in the first three months of referral. When one looks at the totality of persons who access treatment and who wait for a short period of time relative to the long waiters, the average waiting time comes down quite considerably.

Dr. Tony O’Holohan

This brings up the issue of prioritisation. In that context, which was referred to in the Comptroller and Auditor General's report, there is by implication the fact that not all conditions or cases will represent the same degree of priority or should do so.

People who are waiting for long periods will wait for some of the reasons Mr. Lyons outlined but the process is a complex one based on the clinical assessment of people by individual clinicians, not just at a particular point in time but on an ongoing basis. These people come back and are reviewed on an ongoing basis at three monthly or six monthly intervals on an out-patient basis with their general practitioner who will maintain a relationship with the consultant. If deterioration takes place either at the level of symptomatology, ability or disability, that can then lead to a situation whereby the GP makes a representation, or others may make representations, to the consultant to move that person up the waiting list. That happens all the time.

The management of the individual waiting list and the decisions about when people are brought forward from the waiting list are not always next-in-turn matters. It is a dynamic situation in which individual clinicians, based on a wide variety of clinical criteria, will make the decision as to which patients are brought forward at a particular time.

I thank Mr. Lyons and Dr. O'Holohan for that. However, we are speaking about human hardship. Can anyone tell me that great hardship and severe pain is not suffered by the 1,300 people? I assume that a consultant placed them on the list in the first place. Is that not sufficient evidence that they had a medical problem? Can anyone say there is not significant human hardship in this regard? I am delighted with the improvement but averaging can be a dangerous and misleading business. There is an old saying in my part of the world that the man that had his head in the fire and his feet in the fridge was, on average, all right. Averages are of little use to the 1,300 people who may be suffering acutely while none of the initiatives seems to be of use to them.

Mr. O’Byrne

I note that the figures quoted are for the end of 2002. Notwithstanding the fact that the national treatment purchase fund scheme figure deals with surgical operations only, our figures for the end of 2003, based on returns supplied by the hospitals, show that no more than 250 people were waiting more than 12 months for operations. They are people who had been treated, offered treatment or validated off waiting lists. We are saying to people who are on waiting lists for surgical procedures that an adult who has been on a waiting list for six months or a child who has been on a waiting list for three months will be facilitated. We have halved the barrier in most places from the initial 12 months for adults and six months for children. If people contact us on the lo-call line, we are prepared to facilitate them.

Mr. Lyons has said there is almost 100% bed capacity usage in the Eastern Regional Health Authority area. It is generally known that every available bed and everything that moves as a bed is filled. How many beds are closed at present? Are any beds closed in the area under Mr. Lyons's jurisdiction?

Mr. Lyons

There are 89 beds closed at the moment but some of those are closed for refurbishment. We are in discussions with the acute hospitals with a view to re-opening those beds. One of the problems is the availability of nurses to support the opening of the beds. The Secretary General mentioned the dynamic of staffing the health system and that if beds are closed and staff let go it is very difficult to reverse that trend in the short term. With recruitment initiatives ongoing in the region, we are optimistic that most if not all of those beds will be opened in the medium term.

Mr. Lyons stated that there is a bed deficit of 1,276 in his functional area. Would he expand on that, because it is a very large figure?

Mr. Lyons

This is based on a regional review of bed capacity requirement which was undertaken by the authority a number of years ago. It was fed into the national review of bed capacity which recommended that there should be 3,000 additional beds put into the system nationally over the next seven to ten years. In implementing that, we got approval from the Department for the opening of 300 additional beds in the region between 2002 and 2003. By its very nature the provision of beds and the commissioning of beds in the acute sector has to be done over the medium to long term. There are capital considerations, manpower planning considerations, and then there is the commissioning and recruitment of the staff. That takes time. As of the end of 2003 we had already put in 25% of the requirement that we have identified for the region.

If that is the case, as of now the only beds that are certain to be opened are the 89 that are closed. They are the ones that could be opened. Is that right?

Mr. Lyons

Yes. However, we have already put in 300 additional beds to the bed stock over and above the ones that were there in the 2001 analysis that the region did on bed capacity requirements.

What I am getting is, if the systems are to work as well as we hope they will in 2004 and 2005, more people will come off the waiting lists in less than 12 months. Is that true?

Mr. Lyons

Yes.

In the Dublin hospitals there would not appear to be much room to channel those people through because the beds are already taken up. Does that mean we will have to use beds that are not taken up, if any, around the country or outside the country? Is it true that there is an ever-increasing flow of patients to hospitals outside the jurisdiction? What are the costs of that type of operation?

Mr. Lyons

There are a couple of issues there. The questions the Deputy raises reflect the interdependencies in the health system. The acute hospital is only one participant in a continuum of care that involves the primary care system, the acute hospital system and continuing care which provides step-down rehabilitation and home care. In the eastern region the streams of referral to the acute system involve emergencies, referral of national specialties, elective work and admissions from the emergency departments into in-patient beds. Each of those pressures tends at any point in time to squeeze out elective work. It is critical to have the whole system working as a single system where general practitioners have information about waiting lists and waiting times in hospitals in their locality so they can make decisions about the timing of referrals. The authority is in the process of developing an ICT system that will enable the provision of information on our website initially and ultimately linking up the primary care systems to the acute system. On the other side of the acute system, we are working to develop the capacity of the community services through the provision of public beds, nursing home places and other forms of care appropriate to patients, such as the Home First project, the Slán Abhaile project, the assisted technology project, and so on.

It is interesting to note in the context of the critical role of the general practitioner that in the Northern Area Health Board, there is one general practitioner for every 2,200 persons in the region. This compares with a national ratio of one general practitioner per 1,600 of the population. It can be seen straight away that the northern area is underresourced in that critical area. The provision of out-of-hours services is another determining factor in the efficacy of the operation of the entire system. We have a number of out-of-hours services located in the acute hospitals in the South Western Area Health Board and in the East Coast Area Health Board. The Northern Area Health Board has it as a priority to develop out-of-hours services in its region. That is another measure which, when put in place, should assist the throughput of patients through the system and increase the capacity of the system generally.

Following Deputy Connaughton's point, could you give the figures relating to bed blocking in Dublin? Is it true that up to 350 people who are clinically fit to be discharged are currently in hospitals in Dublin.

Mr. Lyons

Yes. There are about 300 people in the acute system at the moment who are clinically fit for discharge. A number of those are being moved out under the early discharge scheme agreed with the Department of Health and Children during 2003. We have identified about 250 people who are eligible to participate in that scheme. About 200 of them have been placed. However, there is a residual cohort within the system that does not qualify, for example, for nursing home subvention because their means do not allow that. We are constrained in moving those patients out unless the families are prepared to support them either financially or by taking them home. There is an issue there regarding bed blocking that is constrained by the provisions of the nursing home regulations that remains a challenge for the region.

Is that not a feature of an unbalanced system where investment has been clearly on the hospital side and there has been a lack of development of community-based nursing facilities? What is the average cost of a bed in a private nursing home compared to the cost of a hospital bed? What is the difference?

Mr. Lyons

It is about €700 a week for a bed in a nursing home.

What is the cost of keeping the same patient in a hospital?

Mr. Lyons

It is difficult to be specific.

The average cost of a bed in a public ward must be available.

Mr. Lyons

It effectively depends on the condition of the patient.

What would it cost for a patient who is deemed clinically fit for discharge, who does not require a high level of care?

Mr. Lyons

I will have to come back to the committee on that.

I am surprised you have not got that figure.

Mr. Lyons

It would be of the order of €2,000 to €3,000. I can come back to the committee.

My point is that if 300 people who are clinically fit to be discharged are costing three times what a private nursing home would cost, would it not make sense to free up the beds even if the health board had to pay the costs of the nursing home?

Mr. Lyons

One of the considerations there is that not all of the people in the acute hospitals in the cohort to which the Chairman refers are suitable for placement in a nursing home. They are highly dependent patients who have gone passed their acute phase but may need rehabilitation. Acquired brain injury is a particular problem in the region. We are developing initiatives relating to the placement of persons with acquired brain injury in the community.

Is it not evidence of bad planning that the care needs of people in the community are not anticipated prior to admission, and that there is no partnership with the areas of community care facilities, private nursing homes and so on?

Mr. Lyons

Unlike other health board regions, the eastern region does not have the network of district hospitals that others have. On a population basis, in fact, it is poorly served by the number of public beds in the system. For example, the Northern Area Health Board, which is the third largest board in the country, has only 600 public beds available for a population of 500,000. There is a huge reliance on the nursing home sector. We operate within finite budgets, as we are required to do under the letter of determination of the 1996 legislation. In trying to make the finite allocation for nursing home places go as far as it can, we have shifted the emphasis from the provision of contract beds to subvention. In effect, therefore, we are putting more people through the system on the basis of subvention than we were under the contract beds system. That has increased the capacity of the nursing home system in the eastern region with virtually the same resources as we have had. In addition to the nursing home placements, we have been planning on a patient-centred basis to accommodate the needs of patients in non-institutional settings, particularly in their own homes. We have had significant consultation with patients in developing those systems.

With funding provided by the Department, we are also developing nine community nursing units in the eastern region under the public-private partnership arrangements. When those 450 beds come on stream it will add significantly to the public bed stock in the region.

How soon do you expect to have all those patients discharged into the PPP nursing homes development?

Mr. Lyons

It is difficult to answer that question in simple terms because people are coming into the system all the time who tend to become late discharges. They have different needs. We are always faced with the challenge in the eastern region that one will have a residue of late discharges in acute hospitals. In the last four months, since the early discharge initiative came on stream, we have moved 200 patients out. In the context of bed management in the acute sector, and in the relationship between the acute sector and the health board, it is important that priority be given to the continuous throughput of patients who do not require acute care. That is very much part of our priority and our oversight role with the acute hospitals and the three area health boards.

Hospitals are seeing review patients but would it not be better to refer such patients back to their GP than the consultant? Is the current system not causing many of the waiting list difficulties? If review patients were referred back to their GPs it would free up the system.

Mr. Lyons

One of the statistics for our own out-patients' list shows that about 85% of patients are return patients. In part, that is reflected by the clinical decision-making system we have in the acute service of the eastern region and beyond. The resolution of that lies, to a great extent, in the implementation of the Hanly report, where we would move to a consultant-led service, and consultants would provide services at out-patient departments on a more routine basis than they can at the moment.

Dr. O’Holohan

It is also fair to say that while patients are undergoing repeat visits on waiting lists or waiting to go on such lists in the care of consultants, they are also in constant contact with their GPs. It is not as if one precludes the other. If consultants place individual patients, or are waiting to see individual patients, on waiting lists, it would not be reasonable for GPs to overtake that care and make decisions about the appropriateness or otherwise of——

If they got new patients, would the waiting lists not become shorter?

Dr. O’Holohan

They would. In general, the primary care strategy in place is an attempt to ensure that there is a greater degree of devolution of care from the out-patients' department and the continuous reliance on repeat visitation, where that is appropriate, back into general practice. However, it will not be appropriate in all situations.

One of the points raised with Mr. Lyons was the availability of suitable services after an acute hospital. I dislike intensely some of the terminology being used, such as "bed blockers" and "inappropriately bedded". I take the point by the Comptroller and Auditor General that each one of these people is an individual with a right to receive respect, yet they are not getting it at present. One of the primary recommendations I read in the July 1998 summary, was the development of geriatric day hospitals on the site of acute hospitals. May I ask Mr. Kelly how that is progressing? Is progress being made in that respect? It would free up hospital beds in a correct fashion — not by putting people out in the street.

Mr. Kelly

As an area of demand, services for the elderly generally have zoomed up the list of priorities. That is the case whether we are talking about their needs in primary or continuing care or as patients in acute hospitals. Some elements of patients' assessment and rehabilitation can be undertaken in acute hospitals. As a matter of policy, there is ongoing development and progress on that, although I do not have the details of which units are concerned.

As regards continuing care, we have referred to the PPP scheme under which plans are in place for an additional 850 community nursing unit beds between the eastern region and the South Health Board area. It will take some time to go through all the stages of procurement under the PPP system. We are pushing that as hard and fast as we can with a view to getting them in place as quickly as we can.

As regards overall capital development, we are in discussion with the Department of Finance on the capital envelope for the next five years. In that context, we will be trying to give priority to the service needs of older people and some of the other non acute areas.

The single biggest fall in waiting list numbers was back in 1993 and 1994 when a validation was carried out and about one third of people were knocked off the list. I would have presumed that there would be an ongoing review of patients on the waiting list. Arising from some of the comments by the Comptroller and Auditor General — and Mr. Kelly also mentioned some of the difficulties in arriving at figures — is the validation of the waiting list and the avoidance of duplication an ongoing process?

Mr. Kelly

Yes. The validation process in ongoing. Getting a clear read on the extent of the problem we are trying to deal with, both nationally and at health board and hospital levels, has been a priority for the Department over the years. We have spent quite a bit of time with hospitals and health boards in trying to obtain clear accounts of that matter. Part of the difficulty is that the base on which waiting lists are built up comprises the individual lists maintained by clinicians. Therefore, the relevant cases have to be extracted from those lists and assembled in a database but that system has not always been as effective as it should be. I certainly agree with the conclusions in the Comptroller and Auditor General's report that there are still further improvements to be made in improving the information management side of managing waiting lists. The acid test in regard to who should be and who should not be on a waiting list is that when a person is offered a treatment opportunity and he or she is not in a position to take it up, does not take it up or has otherwise been treated, we have got to the point of applying that test through the activities of the national treatment purchase fund. I am quite happy that the validated lists, as we now define them, reflect the real scale of people waiting for a procedure they need.

We were shown figures — again, this arises out of a previous discussion. The Comptroller and Auditor General's report stated that the reported number of patients waiting longer than the maximum time frame has decreased from 14,100 to 8,700. Are those figures accurate? Is it accepted by everyone involved that the figure dropped from 14,100 to 8,700?

Mr. Kelly

Yes.

There is no argument but that those figures are accurate and accepted by all.

Mr. Kelly

No.

As I stated previously, I have considerable reservations about measuring our health service by the length of, or by using, waiting lists. It adds to the black hole concept to which Deputy Naughten referred earlier. The level of activity does not seem to be measured, that is, the number of procedures carried out. There are nine specialties here. Is output measured? Can figures be published on the number of procedures carried out in 2003 for the entire country? Can the public be given a picture of what it is getting for its money? Deputy Boyle referred to value for money. It should be possible to measure output, that is, whether an additional 1 million procedures were carried out. It would appear from the figures given at the outset that this is a very ill nation in that one in four had some type of in-patient treatment. The person paying the bill — the taxpayer — should be able to measure or quantify the value for the amount of money the Minister allocated this year or last year as against four years ago. Is the same number of procedures or is an additional number being carried out? I presume additional procedures are being carried out given new diagnostic procedures and the seven or eight new orthopaedic operations, for instance. Are those procedures being measured? Are there any figures?

Mr. Kelly

There is a well organised data collection system in regard to hospital activity generally under the hospital in-patient inquiry. There is a computerised record of each discharge which covers much detail in regard to the particulars of each discharge. In overall figures we can reliably state, although it is a provisional figure for end 2003, that the total number of discharges was short of 1 million. There were 1 million discharges from the acute hospitals, some of which may have been the same person who was in hospital twice. That is up 4% on the figure for 2002. Over time one can see a gradual growth in the productivity of the system.

Given much of the ill-informed public commentary on the health system, it is legitimate to ask whether throughput in the Irish hospital system reflects an efficient performance. The best indicators of that are to judge it by the experience of health systems in other developed countries. Among OECD countries, for example, two of the key indicators used in regard to efficiency of throughput are the average length of time people remain in the acute hospitals and the percentage occupancy. There has already been some comment in the eastern region on that point. In regard to average length of stay, we are approximately in the middle of the table, so we are fairly average among OECD countries. In regard to percentage occupancy, we are near the top of the table which suggests that the efficiency with which existing hospital capacity is used in the Irish health system is relatively high in comparison to other OECD countries.

I welcome the report because any information we get or practices measured is a good addition because "if it ain't measured, it ain't done". Of the nine specialties targeted at the time, two, in particular, came through with flying colours, namely, orthopaedics and cardiac surgery. Is there any reason those were targeted? Many of the complaints and much of the publicity related to orthopaedics and cardiac difficulties. Were those specialties targeted specifically among the nine already targeted?

Mr. Kelly

For obvious reasons, cardiac surgery was given particular priority and specific funding was made available, in particular, for cardiac surgery procedures for adults and children. That would account for the leap in performance there. The additional capacity in St. James's Hospital and the extended facilities in that hospital for cardiac surgery were a factor in that also.

In regard to orthopaedics, and going back to Deputy Connaughton's point about the degree of suffering attached to particular conditions, joint replacements for people with arthritic joints and so on were a priority. Increased attention was given to those two areas.

The different methods of reporting were referred to. Is it intended to bring in a standard reporting method whereby everybody is playing by the same set of rules? If somebody reports a patient as suitable for a waiting list, is the system the same in Dublin, Cork, Letterkenny or wherever?

Mr. Kelly

It is. We would look to a co-ordinating role to be exercised by the national treatment purchase fund in managing waiting lists plus the developments in play in regard to improved information systems. There are ongoing developments in regard to the pay side of the personnel and pay roll systems and to financial systems to upgrade financial accountability and management. We are on the cusp of a decision in regard to hospital activity systems and the funding for this development and what we need to do in 2004 is in place in the increased capital allocated we have received for 2004. That is a priority.

I have a few points of conflicts. It is standard for every witness to welcome the Comptroller and Auditor General's comments and reports. Having welcomed it, are there any points of conflict for Mr. Kelly in it? I have a few which I will come to, but is there anything which jumps out at Mr. Kelly and with which he has a difficulty? I refer to the question of rewarding the good hospital to which Mr. Lyons referred in his report and with which I would like to deal. I fully agree with the case mix concept brought in but does Mr. Kelly have any difficulty with the points raised by the Comptroller and Auditor General in regard to what we might or might not do?

Mr. Kelly

I have done the type of work — policy analysis and policy review work — reflected in this report. That type of work brings an objectivity to the analysis of a policy question, which is always welcome. Any two individuals looking at a particular set of circumstances and a particular experience can come up with different nuances in the way they would interpret and analyse it and so on. To be honest, I would not like to become involved in providing a blow by blow account. Where we had points to make, we made them in our initial reaction to the draft report. Some of those points were adequately taken on board while there were some differences of view in respect of others, which is legitimate in an exercise of this type.

I agree with Deputy Fleming that the Eastern Health Board has come out of this badly for a number of reasons, including the fact that Tallaght could not avail of it and that 32% of all patients come from outside the region. I subscribe totally to the argument that there is a need for a separate initiative, perhaps similar to the treatment purchase fund.

The Chairman referred to the danger involved in allowing a two-tier health system to develop. This matter has arisen on a regular basis without anyone following through on it. For example, there is the argument that people who pay BUPA and VHI should not do so or they should not receive anything in return for doing so. Will our guests comment on the difference in the waiting times experienced by public and private patients? Has any work been carried out in this regard?

Mr. Kelly

We have not specifically carried out work on that matter. As stated earlier, that data, if I recollect it correctly, is based on CSO data that was incorporated in the report. I do not have reason to disagree fundamentally with what is coming through from the data, neither can I say, however, that work has been done which would verify it or otherwise. There is an ongoing concern on our part to ensure that people who depend on the public system, as distinct from those who have a choice, receive their fair share of treatment opportunities in that system. We rely on the existing rules of engagement in this regard and the management of these at hospital level to achieve a fair result for public patients.

I have already stated that there are pressures at work in the daily practical management of hospitals which mean that the 80-20 rule is not always observed. However, in part inspired by the findings of the CSO and as indicated in the Comptroller and Auditor General's report, this is something at which we are actively looking. We were in communication with the boards during 2003 in respect of the management of the public-private mix. I do not want to state categorically what the Department will or will not do but I am in a position to indicate that this matter is on our agenda, particularly in respect of the management of services, but also in the context of the forthcoming negotiations on new contracts for consultants.

Is the common contract up for review?

Mr. Kelly

Yes.

I had the privilege of chairing a health board on four occasions. If reference was made to individual cases, consultants always stated that every patient was treated on the basis of medical needs. Is there not a conflict between that rule and the targeting of people simply because they are on the long-term list or they have been waiting longest? Surely both objectives cannot be achieved. The Comptroller and Auditor General might have referred to targeting to some extent. Are we moving away from the often expressed belief of consultants that nothing other than medical needs come into play when making decisions? If Mr. Kelly gets stroppy about it, I will ask when he qualified to practice. Is there conflict between the two objectives?

Mr. Kelly

"Conflict" is not the term I would use. However, a trade-off must certainly be made between addressing the needs of individual patients on the basis that they have been waiting longest and doing so on the basis that they have specific clinical needs which involve, in clinical terms, a degree of urgency or a lesser degree of urgency. Managing that trade-off is the business of clinicians and managers, particularly in light of the fact that there is a limited pool of funding and resources available which must be distributed in a way which addresses both objectives. I could not stand over a situation where we would say that there is a simple decision rule to apply, namely, that people who have been waiting longest must be treated first. That would not be ethical or appropriate.

So it does not appear that those who have been on the list longest are being targeted. Perhaps it should be called the long-term waiting list initiative or something else. Are people going to be treated because they have been on the list for a long period? Did all consultants co-operate with this initiative or did arguments occur? Is there all-Ireland co-operation in respect of it, particularly in terms of the purchase of treatment? I was chairman of the health board when it was decided to send orthopaedic cases to Belfast, which has one of the best trauma hospitals in Europe that was under-used. It was stated initially that these people would all die in the helicopters travelling to Belfast but they all survived and it only cost half as much to treat them as it would have cost down here. Is there all-Ireland co-operation in respect of the initiative and do all consultants subscribe to it?

Mr. Kelly

On the international or cross-Border co-operation, perhaps Mr. O'Byrne could offer some comment from the point of view of the NTPS. As a matter of principle, there are open arrangements not just in respect of Northern Ireland, but also in respect of the UK more generally. Service trading occurs on both a North-South and South-North basis in regard to various specialties at present. For example, the various health boards, North and South, are actively involved in arrangements where they would complement each other's services through referrals.

On the NTPS, treatments have been purchased both within the private system in Ireland and through referrals outside the country. One of the issues that has arisen — Mr. O'Byrne will be in a better position to comment — revolves around the willingness of patients to take up a treatment opportunity outside the jurisdiction. We can develop that point if Members so wish.

Does Mr. O'Byrne wish to comment?

Mr. Pat O’Byrne

In considering the provision of hospital care, we have been struck by the fact that the hospital with the longest waiting list is not necessarily in the best position, for various reasons, to deal with that list at any given time. Hence it is necessary to refer people elsewhere. It is also necessary to bring mobility into the system. That is one of the reasons we have contracted primarily with the private hospital system because it is not burdened with the accident and emergency tag. Private hospitals can decide to whom treatment can be given at any given time. The latter cannot be done if a hospital is operating an accident and emergency department in the public system. We have also contracted with a hospital outside Derry and four hospitals in the UK which are part of the BMI and BUPA groups. If people are prepared to move around the system to some extent, they could be treated more quickly. On the basis that local hospitals are not always in a position to deal with every case that presents, mobility is required in the system to allow it to deal with such cases.

I hope this scheme will come to the aid of the Eastern Health Board which has a problem in terms of capacity. I appreciate that it is up to a patient to decide whether to travel elsewhere for treatment.

Mr. O’Byrne

For example, we have sent neurosurgery patients from Beaumont Hospital to Cork and they have been dealt with satisfactorily.

The issue of ring-fencing the money was raised. The Comptroller and Auditor General often refers to it getting to the point of wasting money. Is it easy to ring-fence money for such a project or is it a difficult process? Would more be spent trying to achieve it than doing it? We all subscribe to the objective of ring-fencing the money but, in practical terms, can it be done?

Mr. Kelly

Ring-fencing can mean a number of different things. An extreme interpretation is that every last euro can be traced to a particular waiting list procedure. The Department allocates funding for the waiting list initiative year on year to health boards and the ERHA in the knowledge that a significant proportion is pre-empted in supporting staff and other services that are part of the base service level and the core funding for the health board. It is still ring-fenced in that it supports activity. By increasing elective activity, it is designed to ensure waiting lists are not increased.

Discretionary spending by boards or hospitals each year is ring-fenced and can be ring-fenced specifically to this area. However, there is an overlay in regard to the health system that applies to all specifically targeted funding. There is an overriding requirement on the accountable person in each board and the ERHA to break even on their budgets at year end and that requires a virement between different subheads of the determination. It would not necessarily follow that the full amount allocated under any heading would be spent precisely on that area.

I welcome the flexibility in the scheme. The Comptroller and Auditor General referred to the employment of additional managerial staff in some cases to process the waiting list while, in other cases, work was bought out or staff worked overtime. I am glad the flexibility was provided but I recognise the difficulty in trying to measure the impact. There was a need for flexibility because it was too rigid in the past and the money was spent inappropriately on policies. People will say operations should be carried out rather than hiring additional staff, but that is an easy comment to make. The Comptroller and Auditor General states on page 36: "The number of long waiting patients may be capable of being addressed by more efficient allocation of WLI funds and the use of the National Treatment Purchase Fund to treat cases backlogged due to capacity constraints." I presume this refers to Tallaght where there was 105% occupancy. Is that what the Comptroller and Auditor General was referring to in the report?

Mr. Purcell

It looks at the two aspects in broad terms but recognises that the impact of the national treatment purchase scheme has a big part to play in this. As a result of the Department's review, and not only my report, as the Accounting Officer said, it has decided to go this way and it certainly should improve things.

I asked earlier about the role of the consultants. According to the report, "it would be necessary in applying the funds to specify it as a general rule all patients waiting longer than the target time should be treated before patients waiting less than the target time." That conflicts with the belief that one is treated on the basis of medical need immediately. No rules were set but this rule cannot be set because it would be a direct conflict. Is that correct?

Mr. Purcell

I identify precisely with what the Accounting Officer said in this regard. There must be a tension or a trade off because, ultimately, clinicians must make certain decisions. However, it made it difficult to define the waiting list initiative in the particular terms set out when one must have a clinician's discretion.

This is a fascinating report and I hope it will give a nudge to a number of issues. It will be seriously considered because there is a need for external purchasing. A number of private hospitals are not operating at full capacity and they must be part of the system but the difference is how that is done. There is no shortage of cash and it has all been spent. Hopefully, that will continue.

I am unclear as to where the report stands. I have read it and listened carefully to the discussion. The scheme was in place for ten years and it cost €246 million, of which €172 million was spent in the latter five years. The committee has examined how much was spent, how many people were on waiting lists at different times, how long they were on the lists and the total number of procedures done in different years. However, what did the State get for the investment of €172 million? I understand the big picture and the lack of information in the Comptroller and Auditor General's report. However, there is no question the position has improved and it must be borne in mind that, while €172 million was spent on the initiative over the five years, the budgetary allocation to the Department of Health and Children increased significantly over the same period. There is a number of variables but I am struggling to tie in the sum of €172 million.

I do not want to go back over all the arguments but Mr. Lyons said he could identify the number of procedures carried out in his area under the initiative for the years 2001 and 2002. That is significant because his region used a great deal of the money in the past two years. His board received €21 million out of a total of €43 million, almost 50%, in 2002 and this was similar to 2001. If we are to make sense of the report, a breakdown of the number of procedures is required. We know where the money went hospital by hospital and region by region, but we cannot say how many procedures resulted for the various amounts expended. That is the kernel of what we are doing in terms of value for money.

I accept Mr. Kelly's comment that the position has dramatically improved. The total number of patients on waiting lists and the times they are waiting have improved significantly but the purpose of the report was to determine whether the initiative provided value for money. While figures are not available for the ten years, I was encouraged that Mr. Lyons said he could provide figures for more recent years. Expenditure in 2001 and 2002 accounts for almost 40% of total expenditure over the ten years of the scheme. It would be worth carrying out a further analysis of the scheme. I do not know if the other health boards throughout the country are as efficient. However, as Mr. Lyons's is the largest figure, I suggest that we consider the matter in more detail unless, as Mr. Kelly said, it is physically impossible. From what I have heard today, this appears to be a necessary exercise, or else the report is lacking.

We cannot go back over the ten-year period. Mr. Lyons was emphatic that he has the information for the last two years, which is 50% of the expenditure. We should look at this issue to try to determine whether we got value for money. Too often we miss the point. The total number of procedures have increased significantly but so also has the budget for the Department of Health and Children. We are trying to tie this down to its initiative. As it is a general comment, I do not know if Mr. Kelly or Mr. Lyons would like to reply to it.

Would anyone like to reply?

Mr. Lyons

Perhaps it will help the committee and prevent us from being called back again to give the specific information. In the two-year period we carried out an additional 13,278 procedures for the investment of €49 million. The important issue is the fact that the unit cost of procedure represents very good value for money when benchmarked against comparable prices in the private sector and, more recently, the national treatment purchase fund.

Over the three-year period we had been commissioning waiting list work, the unit cost has decreased against a background of medical inflation of 9% per annum. I would like to think that not only do we give good value to our own providers in the region, but we give good value to health boards from outside the region when dealing with 30% of referrals from outside the eastern region.

I thank Mr. Lyons for his comments. The information he has provided is very useful. As a lay person, it was the type of information I was trying to get. If we are looking at value for money and at how one performed, it is the first time since the meeting began that the fact that the prices per procedure were better than in the private sector and so on was referred to. This is precisely what we are looking at in the context of value for money. I do not know if anyone else wishes to follow along these lines. I do not mean the health boards should necessarily be brought in here but it would be useful if they could supply the information available to them.

Mr. Purcell

Without in any way wishing to go against what Mr. Lyons has said, there must be a question mark over these figures. Our experience — this is recorded in the report — in going into the different hospitals, including some in the Eastern Regional Health Authority area, indicated different ways of calculating what had been done. We tried to establish what was attributable to the extra money given to fund the core activities of the acute hospitals and what was attributable to the waiting list initiative. I said in the report that, since it was established in 2000, the Eastern Regional Health Authority took a very pro-active approach in trying to get this information out. During that time, some of the bases for estimating the procedures attributable to the waiting list activities were not consistent between different hospitals. There are question marks over some hospitals. The hospitals were not formally audited. The figures exist——

The point is——

Mr. Purcell

——but one will not get the figures over the years 1993 to 1998, inclusive.

The years 2001 to 2002 accounted for 35% or 40% of the total expenditure of the ten-year scheme, which are the last two years. These are the years for which Mr. Purcell identified the ERHA as probably well equipped from an accounting point of view. These account for 50% of that expenditure. It is worth considering this factor if we are talking about value for money. Can we compare like with like? Can we compare what the additional marginal cost of an additional procedure in St. James's Hospital is and are we getting value for money?

Mr. Lyons

Can I reflect the Secretary General's point about the commissioning authority taking figures in good faith to a certain extent? When one sets the returns for the investment against the contracting and commissioning criteria — it requires signing off by the chief executive in each of the hospitals that commissioning waiting list initiative work has been undertaken with the funding given including reporting on that basis and our subsequent system of monitoring would endorse that — we can take it that the figures presented would reflect a return on the investment through making the initiative work.

The Comptroller and Auditor General raises a valid point about the responsibility of the commissioning agency, namely, the ERHA, to get deeper into the system and audit or validate what is going on within acute hospitals. While this will be a complex issue involving clinicians as well as the management of hospitals, we do not preclude it. We are about to go into one of the hospitals in the region to have an in-depth validation of their list because we are not happy with the latest return we received.

If we were to have this meeting 12 months from today, we would have a much sharper focus because of the report before us. We certainly have benchmarked the system and there should be no problem measuring graphically what will happen in regard to both the initiatives over the next 12 months. I suggest this is the line we take.

How many patients have been treated to date under the national treatment purchase fund?

Mr. O’Byrne

Approximately 10,500 patients have been treated. We treated approximately 2,000 patients in 2002, 8,000 last year and the balance this year, which brings the figure this year to approximately 10,500.

What was the total spend on the 10,500 patients?

Mr. O’Byrne

Patient care costs to date are just under €32 million.

For 10,500 procedures?

Mr. O’Byrne

That is a rough estimate.

Does this include operational or administration costs?

Mr. O’Byrne

It does not include administration costs.

These are charges for patient care?

Mr. O’Byrne

Yes.

Some 10,500 patients being treated at a cost of €32 million averages out at approximately €3,000 per patient. The figure of 13,000 costing €42 million provided by the Eastern Regional Health Authority averages out at approximately €3,500 per patient. The figures are close enough, depending on the actual patients and their condition.

The meeting should have been about finding out what we are getting for our money. This is the first bit of concrete information I have received in terms of output, costs and value. It is easy to compare these figures. We have a choice with regard to the report. It contains no information regarding the numbers of procedures, their average cost or even an estimate of that. I propose that the committee write to the chief executives of the health boards to give them an opportunity to give us their best information for the last five years, accepting that it will be subject to a health warning and that there are possible anomalies. However, we are all adults and if we get the information we can decide to use it or discard it. The report gives us no information and we are not, therefore, in a position to do anything. The committee should be able to assess the information, accept or reject it or take it with a health warning. We need to do that because we have no idea what was carried out.

When I first read the report I was struck by the absence of detail regarding numbers and I submitted a parliamentary question to the Minister as to the number of procedures carried out annually in the last five years in each of the health board areas. The Minister replied that he would write to the health boards. I received those figures from the Minister this week. They correspond with those given by the Comptroller and Auditor General as the final figures for the Midland and Mid-Western Health Boards. Some information is available and we must have sight of it before we make a judgment as to whether we use it or not.

In fairness to the health boards who have spent €172 million, they must be given an opportunity to explain what they did with it. The report does not say what they actually did. We can then judge accordingly. I do not propose that we invite them to the committee. This can be done by way of correspondence. We can assemble the information and decide what to do with it.

Is the question whether the report being submitted to the committee is a fair and accurate one or not or whether we are using the report as a basis to question whether the waiting list initiative has been effective? I thought the second question was the one the committee was meant to be asking. If it is the former, I do not have difficulty with the report. I feel it is indicative of the information that can be verifiable and of how this programme has succeeded since 1993, and particularly since 1998. I would not want any question mark put over the report itself or the Office of the Comptroller and Auditor General in putting the report together.

I concur with that in this regard. Given that the information we received on this report was the best available — the Secretary General concurred with this — and that the information we would have liked was not available, which is one of those problems we regularly meet in this committee, I believe the Comptroller and Auditor General's report is a fair and honest assessment of what he and his professional people found. It will mean a great deal to the taxpayers in the future because it appears, from all the stakeholders who have spoken today, that in future we will receive the type of information, analysis and assessment that is needed. If that is the case this report has been excellent.

Let us not take sides and start a row or get excited about the wrong thing. Deputy Boyle says this is all about verifiable figures. The Comptroller and Auditor General told us he cannot verify the figures. Any report we have ever received has been used as a tool for trying to advance matters.

It would be nice to know the price per operation. If someone puts in a permanent member of staff as a result of this funding, that effect will trickle down for years to come and the employee will help other cases along the line. Someone else might have used the money to buy five or six operations. We are not comparing like with like. It would be useful to be able to compare the Eastern Regional Health Authority figures with the national purchase scheme, for example, to see if they are in the same ballpark. All procedures should be measured. We have identified hospitals in the past which, in one case, had only one 15th the output of a different hospital in the same country. If we are to measure health expenditure and make recommendations we must know what is being done, who is doing it and whether they are all producing the same amount of work.

Deputy Fleming is only asking us to write to the eight CEOs and request the figures. We can argue afterwards about whether they are accurate or not. It would only cost us the price of eight letters. We have written to individuals and residents' associations, and so on. Are we saying we cannot write to the CEOs of the health boards? It would be useful to get some idea of the figures. I will not object if we decide to leave today's report as it is. I am sure Mr. Kelly has already taken good note of it.

Mr. Kelly

I do not want to interfere with the committee's discussion about how this might be handled. However, in an effort to make a constructive suggestion as to how much of the information available to us is less than 100% accurate, there are firm estimates of activity. I would be inclined to take recent data, particularly in the period 2001-02, as accurate. The Department would have no difficulty, with the assistance of the Comptroller and Auditor General's office or in liaison with the committee, in engaging with the health boards in trying to produce hard data regarding 2001-02.

More importantly, the suggestion has been made by Deputy Connaughton regarding 2004, where we have the opportunity to zone in on this with the single lead agency, the national treatment purchase fund, that we would make a particular point of tracking expenditure under this heading more closely. It must be accepted that part of this would have to be done on an attributable basis because a significant part of the waiting list initiative funding in 2004 will be incorporated in the base allocations of health boards. A statistical exercise will have to be done whereby we analyse hospital activity and attribute a certain proportion of it to the funding under the waiting list initiative, and then there is directly funded activity under the lead of the NTPF, which should be more trackable during 2004. I say this in an effort to be helpful.

It would be helpful if you can forward whatever information you have for the past two years. The fact that you accept Deputy Connaughton's recommendation that we track spending, going forward, is also appreciated.

I propose that we suspend the debate on this issue and that we reflect on the evidence. We will resume in five minutes with a consideration of the accounts of the Eastern Regional Health Authority.

Sitting suspended at 2.50 p.m. and resumed at 3.05 p.m.
Top
Share